• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[Analgesic effect of ketamine in a patient with neuropathic pain].

作者信息

Oye I, Rabben T, Fagerlund T H

机构信息

Farmakologisk Institutt, Blindern, Oslo.

出版信息

Tidsskr Nor Laegeforen. 1996 Oct 30;116(26):3130-1.

PMID:8999575
Abstract

We report the effect of a single daily dose of ketamine in a 54 year old woman with fibromyalgia and severe post-traumatic neuropathic pain. A number of different approaches for pain relief had been tried with little effect. An intramuscular test dose of 0.4 mg/kg ketamine combined with 0.05 mg/kg midazolam lead to analgesia which lasted for almost two days. Long-term analgesia was also obtained by 250 mg/kg ketamine hydrochloride taken orally in the form of capsules every night at bedtime. The patient has now used this dose for nine months. Ketamine is an NMDA receptor antagonist. A single sub-anaesthetic dose of ketamine causes a long-term depression of pain intensity in some, but not in all, patients suffering chronic pain. This effect is distinctly different from the short-lasting (10-30 min) analgesic effect in cases of acute nociceptive pain. The long-term depression of the intensity of chronic pain states may be due to a reversal of NMDA receptor-dependent long-term potentiation of synapses in central pain pathways. By giving ketamine as a single dose at night the mental side-effects are reduced or avoided.

摘要

相似文献

1
[Analgesic effect of ketamine in a patient with neuropathic pain].
Tidsskr Nor Laegeforen. 1996 Oct 30;116(26):3130-1.
2
Prolonged analgesic effect of ketamine, an N-methyl-D-aspartate receptor inhibitor, in patients with chronic pain.N-甲基-D-天冬氨酸受体抑制剂氯胺酮对慢性疼痛患者的长期镇痛作用。
J Pharmacol Exp Ther. 1999 May;289(2):1060-6.
3
Interindividual differences in the analgesic response to ketamine in chronic orofacial pain.慢性口面部疼痛患者对氯胺酮镇痛反应的个体差异。
Eur J Pain. 2001;5(3):233-40. doi: 10.1053/eujp.2001.0232.
4
Perioperative ketamine does not prevent chronic pain after thoracotomy.围手术期使用氯胺酮不能预防开胸术后慢性疼痛。
Eur J Pain. 2009 May;13(5):497-505. doi: 10.1016/j.ejpain.2008.06.013. Epub 2008 Sep 9.
5
Analgesic effect of intravenous ATP on postherpetic neuralgia in comparison with responses to intravenous ketamine and lidocaine.静脉注射三磷酸腺苷对带状疱疹后神经痛的镇痛作用与静脉注射氯胺酮和利多卡因的反应比较。
J Anesth. 2005;19(1):31-5. doi: 10.1007/s00540-004-0273-1.
6
Analgesic effect of subanesthetic intravenous ketamine in refractory neuropathic pain: a case report.鞘内注射亚麻醉剂量氯胺酮治疗难治性神经病理性疼痛的镇痛效果:一例报告。
Pain Med. 2010 Jun;11(6):946-50. doi: 10.1111/j.1526-4637.2010.00863.x.
7
The intravenous ketamine test predicts subsequent response to an oral dextromethorphan treatment regimen in fibromyalgia patients.静脉注射氯胺酮试验可预测纤维肌痛患者对口服右美沙芬治疗方案的后续反应。
J Pain. 2006 Jun;7(6):391-8. doi: 10.1016/j.jpain.2005.12.010.
8
Effects of low-dose ketamine on neuropathic pain: An electroencephalogram-electrooculogram/behavioral study.低剂量氯胺酮对神经性疼痛的影响:一项脑电图-眼电图/行为学研究。
Psychiatry Clin Neurosci. 2002 Aug;56(4):355-63. doi: 10.1046/j.1440-1819.2002.01023.x.
9
Effects of ketamine on acute somatic nociception in wild-type and N-methyl-D-aspartate (NMDA) receptor epsilon1 subunit knockout mice.氯胺酮对野生型和N-甲基-D-天冬氨酸(NMDA)受体ε1亚基基因敲除小鼠急性躯体痛觉的影响。
Neuropharmacology. 2006 May;50(6):741-7. doi: 10.1016/j.neuropharm.2005.11.019. Epub 2006 Jan 19.
10
The role of ketamine in pain management.氯胺酮在疼痛管理中的作用。
Biomed Pharmacother. 2006 Aug;60(7):341-8. doi: 10.1016/j.biopha.2006.06.021. Epub 2006 Jul 5.

引用本文的文献

1
Pharmacodynamic profiles of ketamine (R)- and (S)- with 5-day inpatient infusion for the treatment of complex regional pain syndrome.(R)-和(S)-氯胺酮的药效学特征与 5 天住院输注治疗复杂性区域疼痛综合征。
Pain Physician. 2010 Jul-Aug;13(4):379-87.
2
Management of fibromyalgia: what are the best treatment choices?
Drugs. 2002;62(4):577-92. doi: 10.2165/00003495-200262040-00003.